Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.
Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, Akasaka O, Koga M, Adachi E, Saito M, Nakachi I, Ogura T, Baba R, Ito M, Kiso M, Yasuhara A, Yamada S, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Yamayoshi S, Yotsuyanagi H, Kawaoka Y, Khurana S.
Ravichandran S, et al. Among authors: grubbs g.
Sci Adv. 2021 Mar 5;7(10):eabf2467. doi: 10.1126/sciadv.abf2467. Print 2021 Mar.
Sci Adv. 2021.
PMID: 33674317
Free PMC article.